2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline Dihydrochloride: A Key Intermediate for Ceritinib Synthesis

Essential building block for targeted cancer therapies, enabling advanced pharmaceutical development.

Get a Quote & Sample

Key Advantages

Exceptional Purity

Achieve superior results in pharmaceutical synthesis with a compound boasting purity of ≥98.0%, crucial for Ceritinib synthesis intermediate quality.

Scalable Production

Benefit from advanced synthetic routes designed for cost-effectiveness and scalability, supporting your needs for this essential pharmaceutical intermediate for ALK inhibitors.

Targeted Efficacy

Contribute to life-saving treatments by using this compound as a vital component in creating effective aniline derivatives in cancer therapy.

Key Applications

Pharmaceutical Synthesis

The primary application involves the synthesis of Ceritinib, a targeted therapy for ALK-positive NSCLC, highlighting its role in advancing cancer therapy.

Drug Development

Serves as a fundamental building block in the research and development of new targeted therapies and pharmaceuticals, driven by the need for reliable pharmaceutical intermediates.

Chemical Research

Utilized in advanced organic synthesis to create novel compounds and explore new reaction pathways, demonstrating its value in fundamental chemical research.

Oncology Treatments

Its significance is underscored by its role in producing ALK inhibitors, crucial for treating specific types of lung cancer, making it a key component in modern oncology drug development.